BIOMAT Database Logo BIOMAT Database Logo

Loss of heterozygosity and overexpression of the p53 gene in ovarian carcinoma. 1994

T S Frank, and R E Bartos, and H K Haefner, and J A Roberts, and M D Wilson, and G P Hubbell
Department of Pathology, University of Michigan Medical School, Ann Arbor.

Mutation and allelic loss of the p53 gene have been demonstrated in a variety of human cancers. In this study, DNA was extracted from formalin-fixed paraffin sections of ovarian carcinoma from 33 patients informative for a restriction fragment length polymorphism (RFLP) for BstU 1 within the 4th exon of the p53 gene. Allelic loss of p53 as indicated by loss of heterozygosity for this RFLP was demonstrated in 16/33 cases (48%). Because immunoreactivity for p53 correlates closely with the presence of mutation in the p53 gene, we performed immunohistochemical staining with the monoclonal antibody PAb1801. Diffuse nuclear p53 immunoreactivity was observed in 16 of the 33 (48%) informative cases used for loss of heterozygosity analysis (37/80 (46%) cases of ovarian carcinoma overall). A significant correlation (Fisher's exact test, P = 0.04) was observed between p53 overexpression and allelic loss. We found no evidence of association of p53 allelic loss or overexpression with advanced stage or other clinical or pathologic prognostic parameters. We conclude that mutation and allelic loss of p53 are common and probably related events in the development of ovarian carcinoma. This study demonstrates the use of paraffin sections in the analysis of p53 alterations in neoplasia.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D012150 Polymorphism, Restriction Fragment Length Variation occurring within a species in the presence or length of DNA fragment generated by a specific endonuclease at a specific site in the genome. Such variations are generated by mutations that create or abolish recognition sites for these enzymes or change the length of the fragment. RFLP,Restriction Fragment Length Polymorphism,RFLPs,Restriction Fragment Length Polymorphisms
D002872 Chromosome Deletion Actual loss of portion of a chromosome. Monosomy, Partial,Partial Monosomy,Deletion, Chromosome,Deletions, Chromosome,Monosomies, Partial,Partial Monosomies
D005260 Female Females
D006579 Heterozygote An individual having different alleles at one or more loci regarding a specific character. Carriers, Genetic,Genetic Carriers,Carrier, Genetic,Genetic Carrier,Heterozygotes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D015139 Blotting, Southern A method (first developed by E.M. Southern) for detection of DNA that has been electrophoretically separated and immobilized by blotting on nitrocellulose or other type of paper or nylon membrane followed by hybridization with labeled NUCLEIC ACID PROBES. Southern Blotting,Blot, Southern,Southern Blot

Related Publications

T S Frank, and R E Bartos, and H K Haefner, and J A Roberts, and M D Wilson, and G P Hubbell
Loss of heterozygosity and overexpression of p53 gene in human primary prostatic adenocarcinoma.
December 1994, Diagnostic molecular pathology : the American journal of surgical pathology, part B,
T S Frank, and R E Bartos, and H K Haefner, and J A Roberts, and M D Wilson, and G P Hubbell
Overexpression of the p53 protein and allele loss at 17p13 in ovarian carcinoma.
January 1992, British journal of cancer,
T S Frank, and R E Bartos, and H K Haefner, and J A Roberts, and M D Wilson, and G P Hubbell
Pleomorphic carcinoma of the lung associated with loss of heterozygosity of p53 gene.
June 2005, The Tohoku journal of experimental medicine,
T S Frank, and R E Bartos, and H K Haefner, and J A Roberts, and M D Wilson, and G P Hubbell
Bilateral adrenocortical carcinoma showing loss of heterozygosity at the p53 and RB gene loci.
June 1996, Cancer genetics and cytogenetics,
T S Frank, and R E Bartos, and H K Haefner, and J A Roberts, and M D Wilson, and G P Hubbell
Loss of heterozygosity and p53 gene mutations in breast cancer.
January 1994, Cancer research,
T S Frank, and R E Bartos, and H K Haefner, and J A Roberts, and M D Wilson, and G P Hubbell
Loss of heterozygosity of p53 gene and p53 protein expression in human colorectal carcinomas.
August 1991, Cancer research,
T S Frank, and R E Bartos, and H K Haefner, and J A Roberts, and M D Wilson, and G P Hubbell
Clonal origin of epithelial ovarian carcinoma: analysis by loss of heterozygosity, p53 mutation, and X-chromosome inactivation.
December 1992, Journal of the National Cancer Institute,
T S Frank, and R E Bartos, and H K Haefner, and J A Roberts, and M D Wilson, and G P Hubbell
Loss of heterozygosity on chromosome 6q27 and p53 mutations in epithelial ovarian cancer.
July 1998, Medical oncology (Northwood, London, England),
T S Frank, and R E Bartos, and H K Haefner, and J A Roberts, and M D Wilson, and G P Hubbell
Loss of heterozygosity and analysis of mutation of p53 in hepatocellular carcinoma.
January 1995, Journal of gastroenterology and hepatology,
T S Frank, and R E Bartos, and H K Haefner, and J A Roberts, and M D Wilson, and G P Hubbell
p53 protein overexpression and allele loss of p53 gene in gastric adenocarcinoma.
August 1994, Journal of Korean medical science,
Copied contents to your clipboard!